Rfg Advisory, LLC Biogen Inc. Transaction History

Rfg Advisory, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$282.99 - $369.05 $181,679 - $236,930	-642 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $166,278 - $266,243	642 New	642 $222,000
Q1 2020 Apr 17, 2020	SELL	$268.85 - $341.04 $321,006 - $407,201	-1,194 Closed	0 $0
Q4 2019 Jan 22, 2020	SELL	$220.06 - $304.07 $301,042 - $415,967	-1,368 Reduced 53.4%	1,194 $354,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $165,254 - $185,348	760 Added 42.18%	2,562 $596,000

Q2 2019 Aug 23, 2019	BUY	$219.29 - $241.72 $111,180 - $122,552	507 Added 39.15%	1,802 $421,000
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $283,980 - $313,027	1,295 New	1,295 $302,000

1,047

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $33B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Rfg Advisory, LLC with notifications on news.